{{Rsnum
|rsid=3218625
|Gene=PTGS2
|Chromosome=1
|position=186674409
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.004591
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PTGS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 0.0 | 8.3 | 91.7
| JPT | 0.0 | 7.3 | 92.7
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 8.3 | 91.7
| CHD | 0.0 | 2.8 | 97.2
| GIH | 0.0 | 3.0 | 97.0
| LWK | 0.0 | 1.8 | 98.2
| MEX | 0.0 | 5.3 | 94.7
| MKK | 0.0 | 1.3 | 98.7
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19347867
|Title=Cyclooxygenase-2 Gly587Arg variant is associated with differential enzymatic activity and risk of esophageal squamous-cell carcinoma.
}}

{{PMID Auto
|PMID=21304218
|Title=Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}